The relationship between albuminuria and hormone therapy in postmenopausal women

American Journal of Kidney Diseases

Volumn 45, Issue 6, 2005, Pages 1019-1025

  Agarwal, Mamta ^a   Selvan, Vani ^a   Freedman, Barry I ^a   Liu, Yongmei ^a   Wagenknecht, Lynne E ^a  

^a WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

Author keywords

Hormone therapy; Postmenopausal; Urine albumin creatinine ratio (ACR); Women

Indexed keywords

ESTROGEN; PROGESTERONE;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; DEMOGRAPHY; DIABETES MELLITUS; FEMALE; FOLLOW UP; HORMONAL THERAPY; HUMAN; HYPERTENSION; INSULIN RESISTANCE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MICROALBUMINURIA; POSTMENOPAUSE; TREATMENT OUTCOME;

AGED; ALBUMINURIA; ANTICHOLESTEREMIC AGENTS; ANTIHYPERTENSIVE AGENTS; ARTERIOSCLEROSIS; BIOLOGICAL MARKERS; BODY MASS INDEX; CARDIOVASCULAR DISEASES; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; ENDOTHELIUM, VASCULAR; ESTROGEN REPLACEMENT THERAPY; ETHNIC GROUPS; FEMALE; FOLLOW-UP STUDIES; HORMONE REPLACEMENT THERAPY; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; INSULIN RESISTANCE; MIDDLE AGED; OBESITY; POSTMENOPAUSE; PROGESTERONE; RISK FACTORS;

EID: 20444403020     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2005.02.025     Document Type: Article

References (53)

1. N. Sultan, M. Nawaz, A. Sultan, M. Fayaz, A. Baseer Effect of menopause on serum HDL-cholesterol level J Ayub Med Coll Abbottabad 15 2003 24 26
2. G. Bulliyya Risk of coronary heart disease in women after menopause J Indian Med Assoc 99 2001 478 480
3. W.B. Kannel, M.C. Hjortland, P.M. McNamara Menopause and risk of cardiovascular disease The Framingham Study Ann Intern Med 85 1976 447 452
4. N.K. Wenger, L. Speroff, B. Packard Cardiovascular health and disease in women N Engl J Med 329 1993 247 256
5. North American Menopause Society Treatment of menopause-associated vasomotor symptoms Position statement of The North American Menopause Society Menopause 1 2004 11 33
6. D.M. Gilligan, D.M. Badar, J.A. Panza, A.A. Quyyumi, R.O. Cannon Acute vascular effects of estrogen in postmenopausal women Circulation 90 1994 786 791
7. O. Lindquist, C. Bengtsson, T. Hansson, B. Roos Effect of age and menopause on osteoporosis Scand J Soc Med Suppl 14 1977 S80 S84
8. F. Grodstein, M.J. Stampfer, G.A. Coltz Postmenopausal hormone therapy and mortality N Engl J Med 336 1997 1769 1775
9. F. Grodstein, M.J. Stampfer, J.E. Manson Postmenopausal estrogen and progestin use and the risk of cardiovascular disease N Engl J Med 335 1996 453 461
10. C.X. Pan, J. Boal Hormone replacement therapy for secondary prevention of coronary heart disease JAMA 281 1999 794 797
11. The Writing Group for the PEPI Trial Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women The Postmenopausal Estrogen/Progestin Interventions (PEPI) trial JAMA 273 1995 199 208
12. S. Hulley, D. Grady, T. Bush for the Heart and Estrogen/Progestin Replacement Study Research Group Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women JAMA 280 1998 605 613
13. Writing Group for the Women's Health Initiative Investigators Risks and benefits of estrogen plus progestin in healthy postmenopausal women Principal results from the Women's Health Initiative randomized controlled trial JAMA 288 2002 321 333
14. R.J. Jarret, G.C. Viberti, A. Argyropoulos Micoalbuminuria predicts mortality in non-insulin dependent diabetics Diabet Med 1 1984 17 19
15. J.S. Jensen, B. Feldt-Rasmussen, K. Borch-Johnsen, P. Clausen Microalbuminuria and its relation to cardiovascular disease and risk factors A population based study of 154 hypertensive individuals J Hum Hypertens 11 1997 727 732
16. G. Remuzzi Abnormal protein traffic through the glomerular barrier induces proximal tubular cell dysfunction and causes renal injury Curr Opin Nephrol Hypertens 4 1995 339 342
17. T.B. Monster, W.M. Janssen, P.E. de Jong, L.T. de Jong-van den Berg Prevention of Renal and Vascular End Stage Disease Study Group Oral contraceptive use and hormone replacement therapy are associated with microalbuminuria Arch Intern Med 161 2001 2000 2005
18. B. Szekacs, Z. Vajo, S. Varbiro Postmenopausal hormone replacement improves proteinuria and impaired creatinine clearance in type 2 diabetes mellitus and hypertension Br J Obstet Gynaecol 107 2000 1017 1021
19. P.J. Manning, W.H. Sutherland, A.R. Allum, S.A. de Jong, S.D. Jones HRT does not improve urinary albumin excretion in postmenopausal diabetic women Diabetes Res Clin Pract 60 2003 33 39
20. L.E. Wagenknecht, E.J. Mayer, M. Reweres The Insulin Resistance Atherosclerosis Study (IRAS) Objectives, design, and recruitment results Ann Epidemiol 5 1995 464 472
21. J.H. Warram, G. Gearin, L. Laffel Effect of duration of type I diabetes on the prevalence of diabetic nephropathy defined by urinary albumin/creatinine ratio J Am Soc Nephrol 7 1996 930 937
22. D.W. Cockroft, M.H. Gault Prediction of creatinine clearance from serum creatinine Nephron 16 1976 31 41
23. F. Akhrass, A.T. Evans, Y. Wang Hormone replacement therapy is associated with less coronary atherosclerosis in postmenopausal women Clin Endocrinol Metab 88 2003 5611 5614
24. T.S. Mikkola, T.B. Clarkson, M. Notelovitz Postmenopausal hormone therapy before and after the Women's Health Initiative study What consequences? Ann Med 36 2004 402 413
25. T.B. Clarkson, M.S. Anthony, T.M. Morgan Inhibition of postmenopausal atherosclerosis progression A comparison of the effects of conjugated equine estrogens and soy phytoestrogens Clin Endocrinol Metab 86 2001 41 47
26. J.E. Manson, J. Hsia, K.C. Johnson Estrogen plus progestin and the risk of coronary heart disease N Engl J Med 349 2003 523 534
27. S. Fenkci, V. Fenkci, M. Yilmazer, M. Serteser, T. Koken Effects of short-term transdermal hormone replacement therapy on glycemic control, lipid metabolism, C-reactive protein and proteinuria in postmenopausal women with type 2 diabetes and hypertension Hum Reprod 18 2003 866 870
28. M.L. Gross, M. Adamczak, T. Rabe Beneficial effects of estrogens on indices of renal damage in uninephrectomized SHRsp rats J Am Soc Nephrol 15 2004 348 358
29. C. Maric, K. Sandberg, C. Hinojoa-Laborde Glomerulosclerosis and tubulointerstitial fibrosis are attenuated with 17β estradiol in the aging Dahl salt sensitive rat J Am Soc Nephrol 15 2004 1546 1556
30. D.H. Kang, E.S. Yu, K. Yoon, R. Johnson The impact of gender on progression of renal disease. Potential role of estrogen mediated vascular endothelial growth factor regulation and vascular protection Am J Pathol 164 2004 679 688
31. B. Antus, P. Hamar, G. Kokeny Estradiol is nephroprotective in the rat remnant kidney Nephrol Dial Transplant 18 2003 54 61
32. D.M. Herrington, M.A. Espeland, J.R. Crouse III Estrogen replacement and brachial artery flow-mediated vasodilation in older women Arterioscler Thromb Vasc Biol 21 2001 1955 1961
33. M. Gerhard, B.W. Walsh, A. Tawakol Estradiol therapy combined with progesterone and endothelium-dependent vasodilation in postmenopausal women Circulation 98 1998 1158 1163
34. S. Pervin, R. Singh, M.E. Rosenfeld, M. Navab, G. Chaudhuri, L. Nathan Estradiol suppresses MCP-1 expression in vivo Implications for atherosclerosis Arterioscler Thromb Vasc Biol 18 1998 1575 1582
35. K. Ghanam, J. Javellaud, L. Ea-Kim, N. Oudart The protective effect of 17 beta-estradiol on vasomotor responses of aorta from cholesterol-fed rabbit is reduced by inhibitors of superoxide dismutase and catalase Biochem Biophys Res Commun 249 1998 858 864
36. H. Seeger, A.O. Mueck, T.H. Lippert The inhibitory effect of endogenous estrogen metabolites on copper-mediated in vitro oxidation of LDL Int J Clin Pharmacol Ther 36 1998 383 385
37. M.A. Espeland, P.E. Hogan, S.E. Fineberg Effect of postmenopausal hormone therapy on glucose and insulin concentrations. PEPI Investigators (Postmenopausal Estrogen/Progestin Interventions) Diabetes Care 21 1998 1589 1595
38. E.F. Binder, S.J. Birge, W.M. Kohrt Effects of endurance exercise and hormone replacement therapy on serum lipids in older women J Am Geriatr Soc 44 1996 231 236
39. J.I. Cleeman, C. Lenfant The National Cholesterol Education Program Progress and prospects JAMA 280 1998 2099 2104
40. W.H. Sutherland, P.J. Manning, S.A. de Jong, A.R. Allum, S.D. Jones, S.M. Williams Hormone-replacement therapy increases serum paraoxonase arylesterase activity in diabetic postmenopausal women Metabolism 50 2001 319 324
41. M. Elisaf, D.P. Mikhailidis Statins and renal function Angiology 53 2002 493 502
42. S. Tsiara, M. Elisaf, D.P. Mikhailidis Early vascular benefits of statin therapy Curr Med Res Opin 19 2003 540 556
43. K.R. Daniel, D.M. Herrington Statin therapy in the Heart and Estrogen/Progestin Replacement Study Minerva Ginecol 55 2003 209 215
44. A.O. Mueck, H. Seeger Statins and menopausal health J Br Menopause Soc 8 2002 141 146
45. M.H. Moghadasian Statins and menopause Drugs 62 2002 2421 2431
46. D.M. Herrington, E. Vittinghoff, F. Lin Statin therapy, cardiovascular events, and total mortality in the Heart and Estrogen/Progestin Replacement Study (HERS) Circulation 105 2002 2962 2967
47. E.J. Lewis, L.G. Hunsicker, R.P. Bainthe, R.D. Rohde The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy N Engl J Med 329 1993 1456 1462
48. R. Trevisan, A. Tiengo North-East Italy Microalbuminuria Study Group Effect of low-dose ramipril on microalbuminuria in normotensive or mild hypertensive non-insulin-dependent diabetic patients Am J Hypertens 8 1995 876 883
49. G. Viberti, N.M. Wheeldon Microalbuminuria reduction with valsartan in patients with type 2 diabetes mellitus A blood pressure-independent effect Circulation 106 2002 672 678
50. H.H. Parving, H. Lehnert, J. Brochner-Mortensen, R. Gomis, S. Andersen, P. Arner The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes N Engl J Med 345 2001 870 878
51. L. Raij Recommendations for the management of special populations Renal disease in diabetes Am J Hypertens 16 suppl 1 2003 S46 S49
52. G. Deferrari, M. Ravera, V. Berruti, G. Leoncini, L. Deferrari Optimizing therapy in the diabetic patient with renal disease Antihypertensive treatment J Am Soc Nephrol 15 suppl 1 2004 S6 S11
53. A.N. Lasaridis, P.A. Sarafidis Diabetic nephropathy and antihypertensive treatment What are the lessons from clinical trials? Am J Hypertens 16 2003 689 697